| Lisa A Mohr, MD | |
|
2450 33rd Ave W, Ste 100, Seattle, WA 98199-3252 | |
| (206) 320-3364 | |
| (206) 320-5869 |
| Full Name | Lisa A Mohr |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 22 Years |
| Location | 2450 33rd Ave W, Seattle, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669534459 | NPI | - | NPPES |
| 8438871 | Medicaid | WA | |
| 0202532 | Other | WA | LABOR AND INDUSTRIES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VX0000X | Obstetrics & Gynecology - Obstetrics | MD00043847 (Washington) | Secondary |
| 207Q00000X | Family Medicine | MD00043847 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Swedish Medical Center | Seattle, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Swedish Health Services | 9537072814 | 323 |
News Archive
The genome encodes the complete information needed by an organism, including that required for protein production. Viruses, which are up to a thousand times smaller than human cells, have considerably smaller genomes. Using a type of herpesvirus as a model system, the scientists of the Max Planck Institute of Biochemistry in Martinsried near Munich and their collaboration partners at the University of California in San Francisco have shown that the genome of this virus contains much more information than previously assumed.
The country has jabbed over 131 million Americans (39.5% of the Total Population), including over 84 million who have been fully vaccinated (25.4%% of the Total Population).
Santarus, Inc. today announced that it has begun patient enrollment in a multicenter, randomized, double-blind, placebo-controlled Phase IIIb clinical study with the investigational drug UCERIS (budesonide) tablets 9 mg to evaluate whether there is an incremental benefit when UCERIS 9 mg is added to current oral aminosalicylate (5-ASA) therapy for patients with mild or moderate active ulcerative colitis who are not adequately controlled on background 5-ASA therapy.
Geisinger Health System is one of only six healthcare organizations in the United States invited by the Mount Sinai School of Medicine and Johns Hopkins University to participate in a new pilot program, Medicare Innovations Collaborative (Med-IC). Med-IC is a national effort to change healthcare policy and improve healthcare for older adults by putting the leading models of geriatric best practices to work in hospital settings.
› Verified 3 days ago
| Entity Name | Swedish Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831139724 PECOS PAC ID: 9537072814 Enrollment ID: O20031112000189 |
News Archive
The genome encodes the complete information needed by an organism, including that required for protein production. Viruses, which are up to a thousand times smaller than human cells, have considerably smaller genomes. Using a type of herpesvirus as a model system, the scientists of the Max Planck Institute of Biochemistry in Martinsried near Munich and their collaboration partners at the University of California in San Francisco have shown that the genome of this virus contains much more information than previously assumed.
The country has jabbed over 131 million Americans (39.5% of the Total Population), including over 84 million who have been fully vaccinated (25.4%% of the Total Population).
Santarus, Inc. today announced that it has begun patient enrollment in a multicenter, randomized, double-blind, placebo-controlled Phase IIIb clinical study with the investigational drug UCERIS (budesonide) tablets 9 mg to evaluate whether there is an incremental benefit when UCERIS 9 mg is added to current oral aminosalicylate (5-ASA) therapy for patients with mild or moderate active ulcerative colitis who are not adequately controlled on background 5-ASA therapy.
Geisinger Health System is one of only six healthcare organizations in the United States invited by the Mount Sinai School of Medicine and Johns Hopkins University to participate in a new pilot program, Medicare Innovations Collaborative (Med-IC). Med-IC is a national effort to change healthcare policy and improve healthcare for older adults by putting the leading models of geriatric best practices to work in hospital settings.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lisa A Mohr, MD Po Box 84026, Seattle, WA 98124-8426 Ph: (206) 783-3948 | Lisa A Mohr, MD 2450 33rd Ave W, Ste 100, Seattle, WA 98199-3252 Ph: (206) 320-3364 |
News Archive
The genome encodes the complete information needed by an organism, including that required for protein production. Viruses, which are up to a thousand times smaller than human cells, have considerably smaller genomes. Using a type of herpesvirus as a model system, the scientists of the Max Planck Institute of Biochemistry in Martinsried near Munich and their collaboration partners at the University of California in San Francisco have shown that the genome of this virus contains much more information than previously assumed.
The country has jabbed over 131 million Americans (39.5% of the Total Population), including over 84 million who have been fully vaccinated (25.4%% of the Total Population).
Santarus, Inc. today announced that it has begun patient enrollment in a multicenter, randomized, double-blind, placebo-controlled Phase IIIb clinical study with the investigational drug UCERIS (budesonide) tablets 9 mg to evaluate whether there is an incremental benefit when UCERIS 9 mg is added to current oral aminosalicylate (5-ASA) therapy for patients with mild or moderate active ulcerative colitis who are not adequately controlled on background 5-ASA therapy.
Geisinger Health System is one of only six healthcare organizations in the United States invited by the Mount Sinai School of Medicine and Johns Hopkins University to participate in a new pilot program, Medicare Innovations Collaborative (Med-IC). Med-IC is a national effort to change healthcare policy and improve healthcare for older adults by putting the leading models of geriatric best practices to work in hospital settings.
› Verified 3 days ago
Claire M Barnett, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2001 E Madison St, Seattle, WA 98122 Phone: 206-328-7722 Fax: 206-720-4657 | |
Dr. Gregory Parada, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8720 14th Ave S, Seattle, WA 98108 Phone: 206-762-3730 Fax: 206-764-5494 | |
Michael S Grabinski, M.D., M.P.H. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 904 7th Ave, 8th Floor, Seattle, WA 98104 Phone: 206-860-4424 Fax: 206-720-7424 | |
Xin Jie Luo, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4755 Fauntleroy Way Sw, Seattle, WA 98116 Phone: 206-201-0551 Fax: 206-201-0552 | |
Brooke Elizabeth Parker, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 11011 Meridian Ave N Ste 201, Seattle, WA 98133 Phone: 206-520-5000 | |
Eunice Mbela Nachinga, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 125 16th Ave E # Csb545, Seattle, WA 98112 Phone: 206-326-3769 | |
Michelle K Xu, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1401 Madison St Ste 100, Seattle, WA 98104 Phone: 206-386-6111 Fax: 206-386-6113 |